Given our findings in the clinical study, we suppose that 1,25(OH)2D3 deficiency may be an important factor contributing to the initiation and progression of vitiligo, as 1,25(OH)2D3 may inhibit CD8+ cytotoxic T cell hyperactivation. This evidence concerns the gene CD8A and vitiligo.